CymaBay Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q3 2012 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: CymaBay Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2012 to Q4 2023.
CymaBay Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$42.5M, a 81% decline year-over-year.
CymaBay Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$102M, a 9.2% decline year-over-year.
CymaBay Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$102M, a 9.2% decline from 2022.
CymaBay Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$93.1M, a 6.31% decline from 2021.
CymaBay Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$87.6M, a 66.5% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2023	-$102M	-$42.5M	-$19M	-81%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-28
Q3 2023	-$82.7M	-$32.2M	-$10.8M	-50.8%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	-$71.8M	-$99K	+$23.7M	+99.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	-$95.5M	-$26.9M	-$2.37M	-9.69%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	-$93.1M	-$23.5M	+$1.03M	+4.21%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-28
Q3 2022	-$94.1M	-$21.4M	+$826K	+3.72%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	-$95M	-$23.8M	-$503K	-2.16%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$94.5M	-$24.5M	-$6.88M	-39.1%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$87.6M	-$24.5M	-$8.64M	-54.4%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-28
Q3 2021	-$78.9M	-$22.2M	-$10.5M	-90.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$68.4M	-$23.3M	-$12.1M	-109%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$56.3M	-$17.6M	-$3.69M	-26.5%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	-$52.6M	-$15.9M	+$14.7M	+48%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-17
Q3 2020	-$67.3M	-$11.7M	+$16.1M	+58%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$83.3M	-$11.2M	+$14.5M	+56.5%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	-$97.8M	-$13.9M	+$10.3M	+42.6%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	-$108M	-$30.5M	-$9.99M	-48.6%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-25
Q3 2019	-$98.2M	-$27.7M	-$6.58M	-31.1%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	-$91.6M	-$25.6M	-$7.68M	-42.7%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	-$83.9M	-$24.3M	-$11.4M	-88.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q4 2018	-$72.5M	-$20.6M	-$16.2M	-372%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-16
Q3 2018	-$56.3M	-$21.1M	-$14.7M	-230%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-05
Q2 2018	-$41.6M	-$18M	-$10.3M	-136%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018	-$31.2M	-$12.9M	-$9.9M	-336%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	-$21.3M	-$4.36M	+$2.33M	+34.9%	Oct 1, 2017	Dec 31, 2017	10-K	2019-02-28
Q3 2017	-$23.7M	-$6.39M	-$730K	-12.9%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-06
Q2 2017	-$22.9M	-$7.63M	-$1.28M	-20.2%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017	-$21.6M	-$2.95M	+$3.94M	+57.2%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-08
Q4 2016	-$25.6M	-$6.69M	-$840K	-14.4%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-28
Q3 2016	-$24.7M	-$5.66M	+$1.07M	+15.8%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-08
Q2 2016	-$25.8M	-$6.35M	+$199K	+3.04%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-10
Q1 2016	-$26M	-$6.89M	-$113K	-1.67%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-11
Q4 2015	-$25.9M	-$5.85M	+$1.76M	+23.2%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-23
Q3 2015	-$27.7M	-$6.73M	-$1.19M	-21.6%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	-$26.5M	-$6.55M	-$796K	-13.8%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-09
Q1 2015	-$25.7M	-$6.78M	-$1.66M	-32.5%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-11
Q4 2014	-$24M	-$7.61M	-$4.16M	-120%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-29
Q3 2014	-$19.9M	-$5.54M	-$4.15M	-299%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-12
Q2 2014	-$15.7M	-$5.75M	-$3.61M	-169%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-11
Q1 2014	-$12.1M	-$5.12M	-$2.7M	-112%	Jan 1, 2014	Mar 31, 2014	10-Q	2014-05-15
Q4 2013	-$9.4M	-$3.45M			Oct 1, 2013	Dec 31, 2013	10-K	2015-03-23
Q3 2013		-$1.39M	-$1.09M	-371%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-14
Q2 2013		-$2.14M			Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-14
Q1 2013		-$2.42M			Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-15
Q3 2012		-$294K			Jul 1, 2012	Sep 30, 2012	10-Q/A	2013-12-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.